HNB
INO icon

Huntington National Bank’s Inovio Pharmaceuticals INO Stock Holding History

Huntington National Bank’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16
Closed -$129 – 4175
2024
Q2 		$129 Hold
16
– – ﹤0.01% 2668
2024
Q1 		$222 Buy
+16
New +$138 ﹤0.01% 2429
2023
Q4 		– Sell
-8
Closed -$39 – 3906
2023
Q3 		$39 Hold
8
– – ﹤0.01% 2816
2023
Q2 		$45 Buy
+8
New +$64 ﹤0.01% 2690
2022
Q3 		– Sell
-33
Closed – – 2190
2022
Q2 		$0 Buy
+33
New +$930 ﹤0.01% 2211

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Huntington National Bank's INO Position: Q3 2024 in Review

Huntington National Bank sold out of Inovio Pharmaceuticals (INO) in Q3 2024, closing a stake of 16 shares — an estimated $129 sold.

Huntington National Bank first reported a position in INO in Q2 2022 and held it in 5 quarters. The position peaked at $222 in Q1 2024. 98 funds tracked by Wall St. Rank hold INO as of Q3 2024.

  • Huntington National Bank reported no remaining Inovio Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Huntington National Bank sold 16 Inovio Pharmaceuticals shares in Q3 2024, an estimated $129.
  • Huntington National Bank first reported a position in Inovio Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Huntington National Bank's Inovio Pharmaceuticals position peaked at $222 in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2024.

Based on Huntington National Bank's 13F filing for Q3 2024, filed 6 Nov 2024.